1[1]Uitto J,Kouba D.Cytokine modulation of extracellular matrix gene expression:relevance to fibrotic skin diseases.J Dermatol Sci 2000; 24 Suppl 1:S60-S69
2[2]Verrecchia F,Mauviel A.TGF-beta and TNF-alpha:antagonis tic cytokines controlling type I collagen gene expression.Cell Signal 2004; 16:873-880
3[3]Verrecchia F,Mauviel A.Control of connective tissue gene expression by TGF beta:role of Smad proteins in fibrosis.Curr Rheumatol Rep 2002; 4:143-149
4[4]Verrecchia F,Mauviel A.Transforming growth factor-beta signaling through the Smad pathway:role in extracellular matrix gene expression and regulation.J Invest Dermatol 2002; 118:211-215
5[5]LeRoy EC,Trojanowska MI,Smith EA.Cytokines and human fibrosis.Eur Cytokine Netw 1990; 1:215-219
6[6]Schiller M,Javelaud D,Mauviel A.TGF-beta-induced SMAD signaling and gene regulation:consequences for extracellular matrix remodeling and wound healing.J Dermatol Sri 2004; 35:83-92
7[7]Grotendorst GR.Connective tissue growth factor:a mediator of TGF-beta action on fibroblasts.Cytokine Growth Factor Rev 1997; 8:171-179
8[8]Leask A,Denton CP,Abraham DJ.Insights into the molecular mechanism of chronic fibrosis:the role of connective tissue growth factor in scleroderma.J Invest Dermatol 2004; 122:1-6
9[9]Feng XH,Derynck R.Specificity and versatility in tgf-beta signaling through Smads.Annu Rev Cell Dev Biol 2005; 21:659-693
10[10]Roberts AB.Molecular and cell biology of TGF-beta.Miner Electrolyte Metab 1998; 24:111-119
